The Justice Department alleged that between 2014 and 2017, physicians performing procedures using THD’s hemorrhoid removal system called the Slide One Kit were required to bill the procedures using a temporary code, according to a Sept. 6 Justice Department news release.
Procedures with T-Codes are considered experimental, so reimbursement for the use of the kit was often denied, according to the release. To avoid denials and increase potential reimbursement, THD allegedly encouraged surgeons to improperly bill Medicare and Medicaid using the T-Code plus an additional CPT code or to bill for CPT codes other than the T-Code.
The claims resolved by the settlement are only allegations and there has been no determination of liability, according to the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
